Methods A retrospective case-control study was conducted using data from the National Institutes of Healths All of Us Database
GSH (M) changes slowly after S switches from 1.8 to S = 1.3
Change in how much or how often you urinate, lower back or side pain, blood in your urine Unusual moods or behaviors, depression, thoughts of hurting yourself or others Blurred vision or any other change in vision Sudden and severe stomach pain, nausea, vomiting, fever, passing gas, stomach upset or bloating, yellow eyes or skin Shaking, trembling, sweating, fast or pounding heartbeat, lightheadedness, hunger, confusion Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing Tell your doctor if you are breastfeeding, or if you have kidney disease, pancreas problems, diabetes, digestion problems, or a history of diabetic retinopathy or depression
For obesity treatment, semaglutide has demonstrated remarkable results
While compounding has legitimate uses, its not appropriate for replacing standard, tested GLP-1 treatments when those are available